Share of oncology biologics and non-biologic market 2003-2013
This statistic depicts the percent distribution of the global oncology market by biologics and non-biologics from 2003 to 2013. In 2009, the global revenues for oncology biologics accounted for 49 percent of the market. The market is shifting towards non-biologic products which require less supportive care use.
